TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY

Clinical trials for TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY explained in plain language.

Never miss a new study

Get alerted when new TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY trials appear

Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New study tracks safety of eplontersen in patients with liver transplants

Knowledge-focused Not yet recruiting

This observational study monitors the long-term safety of eplontersen, a treatment for transthyretin amyloidosis, in patients who have had a liver transplant or have severe liver impairment. Researchers will track side effects, lab changes, and serious health events in about 320 …

Matched conditions: TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY

Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Jun 27, 2026 14:00 UTC

TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY

Get alerted when new TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY trials appear

New study tracks safety of eplontersen in patients with liver transplants